Endoscopic ultrasound-guided biopsy of pancreatic metastases: A large single-center experience

Ihab I. El Hajj, Julia K. Leblanc, Stuart Sherman, Mohammad A. Al-Haddad, Gregory A. Cote, Lee McHenry, John DeWitt

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

OBJECTIVES: This study aimed to describe a single-center experience with endoscopic ultrasound (EUS) features as well as the diagnostic role and clinical impact of EUS-guided fine-needle aspiration (EUS-FNA) and Trucut biopsy (EUS-TCB) in patients with pancreatic metastases. METHODS: Demographic, clinical, EUS, pathological, clinical outcome, and follow-up data of patients who underwent EUS at our institution between October 1998 and March 2010 for a known or suspected pancreatic metastasis were abstracted. RESULTS: Forty-nine patients (23 males; median age, 63 years; range 30-83 years) with 72 pancreatic masses were identified. Primary tumor sites included kidney (21), lung (8), skin (6), colon (4), breast (3), small bowel (2), stomach (2), liver (1), ovary (1), and bladder (1). Of the 72 pancreatic lesions, EUS-FNA of 49 was performed (median, 4.1 passes; range, 2-9 passes) without complications. An EUS-TCB after EUS-FNA was performed in 2 patients and confirmed renal cell carcinoma in one and was nondiagnostic in one. The EUS-FNA provided the first diagnosis of "recurrent malignancy" in all the 44 patients at a median time of 65 months (range, 1-348 months) after diagnosis of the primary tumor. CONCLUSIONS: Endoscopic ultrasound-FNA and EUS-TCB may assist with the cytological diagnosis of pancreatic metastases and may have a major clinical impact.

Original languageEnglish
Pages (from-to)524-530
Number of pages7
JournalPancreas
Volume42
Issue number3
DOIs
StatePublished - Apr 2013

Fingerprint

Neoplasm Metastasis
Biopsy
Endoscopic Ultrasound-Guided Fine Needle Aspiration
Neoplasms
Fine Needle Biopsy
Renal Cell Carcinoma
Ovary
Stomach
Colon
Urinary Bladder
Breast
Demography
Kidney
Lung
Skin
Liver

Keywords

  • Biopsy
  • Endoscopic ultrasound
  • Fine-needle aspiration
  • Pancreatic metastasis
  • Trucut biopsy

ASJC Scopus subject areas

  • Hepatology
  • Internal Medicine
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Endoscopic ultrasound-guided biopsy of pancreatic metastases : A large single-center experience. / El Hajj, Ihab I.; Leblanc, Julia K.; Sherman, Stuart; Al-Haddad, Mohammad A.; Cote, Gregory A.; McHenry, Lee; DeWitt, John.

In: Pancreas, Vol. 42, No. 3, 04.2013, p. 524-530.

Research output: Contribution to journalArticle

El Hajj, Ihab I. ; Leblanc, Julia K. ; Sherman, Stuart ; Al-Haddad, Mohammad A. ; Cote, Gregory A. ; McHenry, Lee ; DeWitt, John. / Endoscopic ultrasound-guided biopsy of pancreatic metastases : A large single-center experience. In: Pancreas. 2013 ; Vol. 42, No. 3. pp. 524-530.
@article{d9b3c24aaeba43488ddb6debed30917c,
title = "Endoscopic ultrasound-guided biopsy of pancreatic metastases: A large single-center experience",
abstract = "OBJECTIVES: This study aimed to describe a single-center experience with endoscopic ultrasound (EUS) features as well as the diagnostic role and clinical impact of EUS-guided fine-needle aspiration (EUS-FNA) and Trucut biopsy (EUS-TCB) in patients with pancreatic metastases. METHODS: Demographic, clinical, EUS, pathological, clinical outcome, and follow-up data of patients who underwent EUS at our institution between October 1998 and March 2010 for a known or suspected pancreatic metastasis were abstracted. RESULTS: Forty-nine patients (23 males; median age, 63 years; range 30-83 years) with 72 pancreatic masses were identified. Primary tumor sites included kidney (21), lung (8), skin (6), colon (4), breast (3), small bowel (2), stomach (2), liver (1), ovary (1), and bladder (1). Of the 72 pancreatic lesions, EUS-FNA of 49 was performed (median, 4.1 passes; range, 2-9 passes) without complications. An EUS-TCB after EUS-FNA was performed in 2 patients and confirmed renal cell carcinoma in one and was nondiagnostic in one. The EUS-FNA provided the first diagnosis of {"}recurrent malignancy{"} in all the 44 patients at a median time of 65 months (range, 1-348 months) after diagnosis of the primary tumor. CONCLUSIONS: Endoscopic ultrasound-FNA and EUS-TCB may assist with the cytological diagnosis of pancreatic metastases and may have a major clinical impact.",
keywords = "Biopsy, Endoscopic ultrasound, Fine-needle aspiration, Pancreatic metastasis, Trucut biopsy",
author = "{El Hajj}, {Ihab I.} and Leblanc, {Julia K.} and Stuart Sherman and Al-Haddad, {Mohammad A.} and Cote, {Gregory A.} and Lee McHenry and John DeWitt",
year = "2013",
month = "4",
doi = "10.1097/MPA.0b013e31826b3acf",
language = "English",
volume = "42",
pages = "524--530",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Endoscopic ultrasound-guided biopsy of pancreatic metastases

T2 - A large single-center experience

AU - El Hajj, Ihab I.

AU - Leblanc, Julia K.

AU - Sherman, Stuart

AU - Al-Haddad, Mohammad A.

AU - Cote, Gregory A.

AU - McHenry, Lee

AU - DeWitt, John

PY - 2013/4

Y1 - 2013/4

N2 - OBJECTIVES: This study aimed to describe a single-center experience with endoscopic ultrasound (EUS) features as well as the diagnostic role and clinical impact of EUS-guided fine-needle aspiration (EUS-FNA) and Trucut biopsy (EUS-TCB) in patients with pancreatic metastases. METHODS: Demographic, clinical, EUS, pathological, clinical outcome, and follow-up data of patients who underwent EUS at our institution between October 1998 and March 2010 for a known or suspected pancreatic metastasis were abstracted. RESULTS: Forty-nine patients (23 males; median age, 63 years; range 30-83 years) with 72 pancreatic masses were identified. Primary tumor sites included kidney (21), lung (8), skin (6), colon (4), breast (3), small bowel (2), stomach (2), liver (1), ovary (1), and bladder (1). Of the 72 pancreatic lesions, EUS-FNA of 49 was performed (median, 4.1 passes; range, 2-9 passes) without complications. An EUS-TCB after EUS-FNA was performed in 2 patients and confirmed renal cell carcinoma in one and was nondiagnostic in one. The EUS-FNA provided the first diagnosis of "recurrent malignancy" in all the 44 patients at a median time of 65 months (range, 1-348 months) after diagnosis of the primary tumor. CONCLUSIONS: Endoscopic ultrasound-FNA and EUS-TCB may assist with the cytological diagnosis of pancreatic metastases and may have a major clinical impact.

AB - OBJECTIVES: This study aimed to describe a single-center experience with endoscopic ultrasound (EUS) features as well as the diagnostic role and clinical impact of EUS-guided fine-needle aspiration (EUS-FNA) and Trucut biopsy (EUS-TCB) in patients with pancreatic metastases. METHODS: Demographic, clinical, EUS, pathological, clinical outcome, and follow-up data of patients who underwent EUS at our institution between October 1998 and March 2010 for a known or suspected pancreatic metastasis were abstracted. RESULTS: Forty-nine patients (23 males; median age, 63 years; range 30-83 years) with 72 pancreatic masses were identified. Primary tumor sites included kidney (21), lung (8), skin (6), colon (4), breast (3), small bowel (2), stomach (2), liver (1), ovary (1), and bladder (1). Of the 72 pancreatic lesions, EUS-FNA of 49 was performed (median, 4.1 passes; range, 2-9 passes) without complications. An EUS-TCB after EUS-FNA was performed in 2 patients and confirmed renal cell carcinoma in one and was nondiagnostic in one. The EUS-FNA provided the first diagnosis of "recurrent malignancy" in all the 44 patients at a median time of 65 months (range, 1-348 months) after diagnosis of the primary tumor. CONCLUSIONS: Endoscopic ultrasound-FNA and EUS-TCB may assist with the cytological diagnosis of pancreatic metastases and may have a major clinical impact.

KW - Biopsy

KW - Endoscopic ultrasound

KW - Fine-needle aspiration

KW - Pancreatic metastasis

KW - Trucut biopsy

UR - http://www.scopus.com/inward/record.url?scp=84884211528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884211528&partnerID=8YFLogxK

U2 - 10.1097/MPA.0b013e31826b3acf

DO - 10.1097/MPA.0b013e31826b3acf

M3 - Article

C2 - 23146924

AN - SCOPUS:84884211528

VL - 42

SP - 524

EP - 530

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 3

ER -